Synthesis and evaluation of 2,9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitors
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 26 (8) , 2173-2185
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81673354)
This publication has 34 references indexed in Scilit:
- 6-Oxooxazolidine–quinazolines as noncovalent inhibitors with the potential to target mutant forms of EGFRBioorganic & Medicinal Chemistry, 2016
- Novel pyrrolo[2,1-f][1,2,4]triazin-4-amines: Dual inhibitors of EGFR and HER2 protein tyrosine kinasesBioorganic & Medicinal Chemistry Letters, 2011
- Targeting the function of the HER2 oncogene in human cancer therapeuticsOncogene, 2007
- EGFR, HER2 and VEGF PathwaysDrugs, 2007
- Lapatinib plus Capecitabine for HER2-Positive Advanced Breast CancerNew England Journal of Medicine, 2006
- Kinetic Analysis of Epidermal Growth Factor Receptor Somatic Mutant Proteins Shows Increased Sensitivity to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, ErlotinibCancer Research, 2006
- The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- Tyrosine Kinase Inhibitors. 12. Synthesis and Structure−Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1997
- Tyrosine Kinase Inhibitors. 9. Synthesis and Evaluation of Fused Tricyclic Quinazoline Analogues as ATP Site Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1996
- Tyrosine Kinase Inhibitors. 10. Isomeric 4-[(3-Bromophenyl)amino]pyrido[d]- pyrimidines Are Potent ATP Binding Site Inhibitors of the Tyrosine Kinase Function of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1996